Is Feel Free Drink Safe? Kratom, Kava, and Addiction Risks

No, the Feel Free drink is not a safe wellness supplement. 

Feel Free drink is a kratom and kava concentrate sold in 2-ounce blue bottles at gas stations, smoke shops, and convenience stores across the United States.

Feel Free Classic, produced by Botanic Tonics, contains mitragynine, the primary psychoactive alkaloid in kratom. Mitragynine binds to mu-opioid receptors in the brain. Regular use produces tolerance, physical dependence, and withdrawal symptoms that closely mirror prescription opioid discontinuation.

Many people who start Feel Free for relaxation or productivity find they cannot stop without significant discomfort. Understanding what this drink actually contains, and what it does to the brain, is the first step toward recognizing when use has crossed into dependence.

Key Takeaways

• According to a 2026 CDC Morbidity and Mortality Weekly Report (MMWR 2026;75(12):157-163), kava-related exposure reports to the National Poison Data System rose 383% between 2011 and 2025, from 57 to 203. Kratom was involved in 30% of 2025 kava reports (61 of 203). Eight kava-related deaths were reported across the full 2000-2025 analysis, five of them since 2011.
• In 2025, Botanic Tonics settled the consolidated class action In Re Botanic Tonics Litigation (which began as Torres v. Botanic Tonics, filed in 2023) for $8.75 million, with final approval entered on October 20, 2025. Botanic Tonics class action lawsuit for $8.75 million. The lawsuit alleged misleading marketing that obscured kratom’s opioid-like properties from consumers who purchased Feel Free between March 2019 and March 2025.
• Kratom’s main active alkaloids, mitragynine and 7-hydroxymitragynine (7-OH), bind the same mu-opioid receptors as opioid drugs. The FDA describes 7-OH as substantially more potent at those receptors than morphine; in mice, subcutaneous 7-OH was about 4.4 to 5.7 times as potent as morphine in analgesia tests (Matsumoto et al., European Journal of Pharmacology 2006;549:63-70).
• In February 2018 the FDA reported that computational modelling predicted 22 of kratom’s 25 studied compounds bind to mu-opioid receptors, and warned of its abuse potential. Kratom remains unscheduled federally, and the FDA states that it is not lawfully marketed in the US as a drug, a dietary supplement or a food additive. Feel Free remains unregulated, and kratom has been banned in Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin.
• Users reporting Feel Free dependence describe consumption escalating over time and repeated failed attempts to stop. This pattern satisfies multiple DSM-5 criteria for a substance use disorder.

What Is Feel Free Drink and What Does It Contain?

Feel Free drink is a 2-ounce concentrated tonic produced by Botanic Tonics, containing kratom leaf extract and kava root extract as its primary psychoactive ingredients in a formulation marketed as a plant-based wellness product.

Kratom: The Primary Ingredient in Feel Free

Kratom derives from Mitragyna speciosa, a tropical tree native to Southeast Asia whose leaves contain over 50 alkaloids (FDA). Mitragynine is the principal one, reported at up to 66% by mass of crude alkaloids in leaf material, though measured content across commercial products ranges from under 1% to about 39% of total alkaloids. Among psychoactive plant-derived substances that produce opioid-like dependence without federal controlled substance classification, kratom occupies a uniquely high-risk position due to its receptor binding profile.

At low doses, mitragynine produces stimulant effects including increased energy and reduced fatigue. At higher doses, it acts as a full mu-opioid receptor agonist, generating sedation, analgesia, and euphoria that mirrrors opioid drug effects. This dual dose-dependent mechanism explains why Feel Free users begin with recreational use and escalate into compulsive daily consumption.

Kava: The Secondary Ingredient and Liver Toxicity Risk

Kava derives from the root of Piper methysticum, a plant native to Pacific Island cultures where it has been consumed ceremonially for centuries. Its active constituents, kavalactones, potentiate GABA-A receptor activity and inhibit voltage-gated sodium channels, producing dose-dependent anxiolysis and central nervous system depression.

Kava is not classified as physically addictive at traditional ceremonial doses. Commercial kava concentrates, including those in Feel Free, deliver kavalactone doses substantially higher than traditional preparations. Sustained daily use of concentrated kava formulations produces hepatotoxicity, with documented liver damage cases appearing in the medical literature and in FDA adverse event reports.

How Feel Free Is Marketed Versus What the Label Contains

Botanic Tonics originally marketed Feel Free primarily around kava, describing the product as made from ancient plants from the South Pacific and Southeast Asia. Marketing materials frequently omitted kratom or buried it in ingredient lists without specifying quantities. The class action alleged that Botanic Tonics sold Feel Free without disclosing the amount or concentration of kratom it contained.

The Torres v. Botanic Tonics lawsuit alleged that kratom, not kava, was Feel Free’s dominant active ingredient. Plaintiffs also claimed Botanic Tonics had targeted individuals with prior addiction histories in social media advertising. Botanic Tonics made Feel Free the ‘official tonic’ of athletics programmes at three universities – Florida State, the University of Southern California and the University of Texas – according to the consolidated class action complaint (N.D. Cal. No. 3:23-cv-01460-VC). Delete the $32 million revenue figure unless a citable source is found.

How Kratom and Kava in Feel Free Affect the Brain

Kratom and kava in Feel Free drive neurochemical changes across the mu-opioid receptor system and GABA-A receptor complex, producing physical dependence through two distinct but additive pharmacological pathways that become progressively harder to reverse with sustained daily use.

Mitragynine and Mu-Opioid Receptor Binding

Mitragynine, kratom’s primary alkaloid, binds to mu-opioid receptors in the brain’s reward circuitry, including the nucleus accumbens and locus coeruleus. This binding produces analgesia, euphoria, and sedation at doses achievable through routine Feel Free consumption. The brain compensates by downregulating mu-opioid receptor density and sensitivity, establishing tolerance.

Receptor downregulation means progressively higher Feel Free doses are required to achieve the same effect. When intake stops, the underregulated opioid system rebounds into a hyperexcitable state. This rebound generates the anxiety, muscle pain, and insomnia characteristic of Feel Free withdrawal, a pattern indistinguishable from prescription medication dependence discontinuation syndromes.

7-Hydroxymitragynine: The More Potent Kratom Alkaloid

7-Hydroxymitragynine (7-OH) is a minor kratom alkaloid present in smaller quantities than mitragynine but substantially more potent at mu-opioid receptors. 7-OH is the kratom alkaloid most associated with abuse potential: in rats it substituted for morphine and was self-administered, while mitragynine was not (Hemby et al., Addiction Biology 2019;24(5):874-885). In mice, subcutaneous 7-OH was about 4.4 to 5.7 times as potent as morphine in analgesia tests (Matsumoto et al., European Journal of Pharmacology 2006;549:63-70).

Concentrated kratom extracts deliver more alkaloid per dose than traditional leaf preparations, which is why the FDA has moved separately against concentrated 7-OH products. Say this as a statement about extracts rather than as a measured property of Feel Free, unless a product assay can be cited. This potency differential explains why Feel Free users report faster dependence onset compared to loose-leaf kratom products. Because kratom’s alkaloids act on the same mu-opioid receptors as opioid drugs, stopping heavy use produces a withdrawal syndrome that resembles opioid withdrawal rather than mild herbal discontinuation – including muscle and joint pain, watering eyes and nose, insomnia, diarrhoea, tremor and craving, with cross-tolerance to morphine (Bin Abdullah, Current Drug Targets 2020;21(15):1566-1579).

Kavalactones and GABA-A Receptor Activity

Kavalactones, the active compounds in kava, modulate GABA-A receptors through a binding mechanism distinct from benzodiazepines. This activity produces sedation and anxiolysis that compounds the mu-opioid receptor effects of kratom. Together, the two mechanisms generate the relaxed euphoria that Feel Free users report and that drives its appeal as an alcohol alternative.

Kavalactone GABA-A activity does not produce physical dependence equivalent to benzodiazepines at standard doses. However, regular kavalactone use generates psychological dependence and behavioral tolerance in daily consumers. Both ingredients put load on the liver: the FDA issued an advisory on kava-associated severe liver injury in 2002 and lists liver toxicity among kratom’s serious adverse events. In CDC’s poison-centre analysis, liver enzyme elevations were reported in 1.7% of single-substance kava exposures but 6.3% of exposures involving both kava and kratom (MMWR 2026;75(12):157-163).

Why the Combination of Kratom and Kava Is More Dangerous Than Either Alone

Kratom and kava each independently depress the central nervous system through separate receptor mechanisms. Combined in Feel Free’s concentrated formulation, mitragynine mu-opioid agonism and kavalactone GABA-A potentiation produce additive CNS depression that accelerates neuroadaptation and dependence onset. Pharmacists describe this combination as creating an overstimulating pharmacological profile that elevates addiction risk beyond either ingredient in isolation.

The combined CNS depression also substantially elevates overdose risk when Feel Free is used alongside alcohol, benzodiazepines, or other opioids. These polypharmacy combinations stack respiratory depressant mechanisms and account for the majority of serious adverse events in kava-kratom poison control data. According to a 2026 CDC MMWR (2026;75(12):157-163), 43% of kava-related exposure reports between 2000 and 2025 involved more than one substance. Kratom is now the dominant co-exposure, accounting for 30% of kava reports in 2025, having overtaken ethanol and benzodiazepines in 2019.

Feel Free Withdrawal: Symptoms and Timeline

Feel Free withdrawal begins within hours of the last dose and follows a trajectory closely resembling opioid withdrawal, reflecting kratom’s mu-opioid receptor-mediated physical dependence with an additional GABA-modulated component from sustained kava exposure.

Feel Free Withdrawal Timeline

The timeline below follows the course of short-acting opioid withdrawal described in the WHO clinical guidelines for withdrawal management — symptoms beginning 8 to 24 hours after the last dose, with an acute phase lasting 4 to 10 days — alongside patterns reported by users. Individual experience varies:

1. Stage 1: Initial onset Anxiety, restlessness, yawning, and rhinorrhea emerge as mu-opioid receptor hyperexcitability develops. Users describe an urgent craving for another bottle. Mild sweating and muscle tension appear.
2. Stage 2: Peak acute phase Muscle aches, nausea, vomiting, and diarrhea intensify as opioid receptor rebound reaches maximum severity. Insomnia develops despite physical exhaustion. Irritability and dysphoria peak during this window, closely mirroring presentations managed under Clinical Opiate Withdrawal Scale (COWS) protocol in clinical detox settings.
3. Stage 3: Sustained acute phase Physical symptoms begin gradual resolution but psychological symptoms, including depression, anhedonia, and intense cravings, remain severe. Users who attempt unsupervised withdrawal most commonly relapse during this stage. Headache, hot flashes, and tremors persist.
4. Stage 4: Sub-acute phase Acute physical discomfort subsides. Persistent insomnia, low mood, cognitive fog, and cravings continue to impair daily function. People who have used kratom regularly for longer report more severe effects on stopping: in a survey of 129 US adults, severity after a day or more without kratom was predicted by the number of weeks of regular use (Smith et al., Frontiers in Pharmacology 2022;13:765917).

Some people who have used heavily for months describe symptoms — particularly low mood, poor sleep and craving — persisting for two to four weeks after the acute phase. WHO puts the acute phase at 4 to 10 days for short-acting opioids and 10 to 20 days for long-acting ones.

When to Seek Medical Help for Feel Free Withdrawal

Feel Free withdrawal is not reliably safe to manage without medical oversight, particularly after high-dose or prolonged daily use. Unsupervised withdrawal risks rapid dehydration from gastrointestinal losses, cardiac arrhythmias from electrolyte depletion, and severe psychological distress including suicidal ideation, which has been reported in case series involving heavy kratom users.

Individuals who have been consuming multiple bottles daily, or who have used Feel Free alongside other CNS depressants, should not attempt cessation without professional supervision. The severity and duration of Feel Free withdrawal are directly proportional to daily dose and duration of use, making clinical assessment essential before discontinuation.

Signs of Feel Free Drink Addiction and Health Risks

Feel Free addiction follows the behavioral and physiological pattern of a substance use disorder, with escalating consumption, failed cessation attempts, and continued use despite documented physical and psychological harm that satisfies multiple DSM-5 diagnostic criteria.

Common Signs of Feel Free Dependence

Common signs that Feel Free use has progressed to physical dependence include:

• Tolerance development: Requiring progressively more bottles per session to achieve the same effect, with users advancing from one to multiple bottles daily over weeks to months of regular consumption.
• Withdrawal-driven use: Consuming Feel Free specifically to prevent anxiety, irritability, or physical discomfort rather than for mood enhancement. This shift marks the clinical transition from misuse to physical dependence.
• Supply preoccupation: Planning daily activities around Feel Free availability, purchasing in bulk from multiple locations, or experiencing significant distress when the product is unavailable.
• Continued use despite harm: Persisting with Feel Free after experiencing liver symptoms, significant weight loss, cognitive impairment, financial strain, or relationship damage directly attributable to the drink.
• Failed cessation attempts: Repeatedly attempting to cut down or stop without success, particularly after experiencing withdrawal symptoms during prior attempts.

Severe Signs of Feel Free Dependence and Physical Complications

Severe signs of Feel Free addiction requiring prompt medical evaluation include:

• High-volume daily consumption: Daily consumption that has escalated over time, with repeated failed attempts to cut down. This intake level delivers kratom alkaloid doses far above any studied clinical range and is associated with accelerated physical deterioration, including dermatological changes and organ dysfunction.
• Skin and dermatological changes: Persistent xerosis, hyperpigmentation, and skin texture changes consistent with kratom-induced dermopathy and kavalactone accumulation. Users describe skin becoming dry, scaly, and discolored with prolonged daily use.
• Hepatic symptoms: Jaundice, abdominal pain, abnormal liver function tests, and abdominal swelling indicating hepatotoxicity from combined kavalactone and kratom alkaloid hepatic burden. These symptoms require immediate medical evaluation.
• Neurological effects: Seizures, confusion, and loss of coordination in the context of combined kratom and kava toxicity. Poison control center data include adolescent cases presenting with seizures and altered mental status following Feel Free ingestion.

Seek emergency care immediately if Feel Free use produces seizures, jaundice, altered consciousness, difficulty breathing, or suicidal ideation.

Long-Term Risks of Daily Feel Free Use

Long-term daily Feel Free consumption produces progressive liver injury through two independent hepatotoxic pathways. Replace the mechanism with the evidence: the FDA warned in 2002 about severe liver injury associated with kava and lists liver toxicity among kratom’s serious adverse events, and CDC’s poison-centre data show liver enzyme elevations in 1.7% of single-substance kava exposures versus 6.3% of exposures involving both kava and kratom (MMWR 2026;75(12):157-163). Combined daily exposure accelerates fibrotic changes that clinical monitoring may not detect until significant damage has already occurred.

Neurologically, regular kratom use produces tolerance, craving, dependence and a withdrawal syndrome that includes depressed mood, anxiety and irritability (Bin Abdullah, Current Drug Targets 2020;21(15):1566-1579). Relapse after withdrawal management is common: WHO notes that withdrawal management on its own rarely produces sustained abstinence and is a first step before further treatment rather than a treatment in itself. Recovery from long-term Feel Free use requires both clinical support and structured behavioral intervention to allow neurochemical restoration.

Treatment for Feel Free Drink Dependence at The Grove Estate

The Grove Estate Addiction Treatment provides medically supervised residential care for adults with kratom and kava dependence, including those who have developed Feel Free use disorder, at its Indiana facility.

1- Medical Detox

Medical detox at The Grove Estate provides 24-hour physician-supervised withdrawal management for adults discontinuing Feel Free and other opioid-like substances. Clinical staff apply symptomatic medication protocols to manage anxiety, insomnia, gastrointestinal distress, and muscle pain throughout the acute withdrawal window. For individuals with suspected hepatic involvement, medical monitoring during detox reduces the risk of undetected liver complications during the most physically vulnerable phase of cessation.

2- Residential Addiction Treatment

Residential addiction treatment at The Grove Estate removes access to Feel Free and other substances while providing a structured therapeutic environment for the sub-acute and early recovery phases. Programming includes individual therapy, Cognitive Behavioral Therapy group sessions, Dialectical Behavior Therapy skills training, and relapse prevention work targeting the craving patterns and behavioral triggers associated with Feel Free dependence. Therapist continuity from detox through residential significantly improves outcomes for kratom-dependent individuals.

3- Dual Diagnosis Treatment

Kratom is often taken to self-treat pain, anxiety, depression or opioid withdrawal, according to the FDA, and people who develop Feel Free dependence frequently describe starting for those reasons. Dual diagnosis treatment at The Grove Estate addresses both kratom and kava dependence and any co-occurring mental health conditions simultaneously, reducing the risk of substituting Feel Free with another psychoactive substance during recovery. Integrated dual-diagnosis care delivers substantially better long-term outcomes than addressing substance use and mental health in separate treatment episodes.

Frequently Asked Questions

What Is Feel Free Tonic Used For?

Feel Free drink is marketed by Botanic Tonics as a tonic for relaxation, focus, and mood enhancement, promoted as a non-alcoholic alternative to social drinking. Users report consuming it to relieve anxiety, manage stress, boost energy, or avoid alcohol. In clinical practice, it is better described as a kratom and kava concentrate. Regular use frequently transitions from intentional wellness consumption to dependence-driven intake. 

Is Kava an Opioid?

Kava is not an opioid. Kava’s active compounds, kavalactones, modulate GABA-A receptors and do not bind to mu-opioid receptors. However, Feel Free combines kava with kratom, which does act on mu-opioid receptors. The opioid-like dependence and withdrawal reported by Feel Free users comes primarily from kratom’s mitragynine and 7-hydroxymitragynine content, not from the kava component. 

Can You Get Addicted to Feel Free?

Yes. Feel Free contains kratom, which produces physical dependence through mu-opioid receptor agonism with sustained use. Users report escalating consumption, withdrawal symptoms when stopping, and repeated failed attempts to quit. These patterns satisfy DSM-5 criteria for a substance use disorder. Addiction professionals now treat Feel Free-specific kratom dependence as a distinct clinical presentation requiring structured medical and behavioral intervention. 

How Much Kratom Is in Feel Free Drink?

The exact mitragynine content per bottle has not been consistently disclosed or independently verified at a standard level. Under the 2025 class action settlement, Botanic Tonics agreed to carry a warning on all kratom-containing Feel Free labels and in its social media advertising: ‘Warning: This product contains leaf kratom which can become habit-forming and cause serious adverse health effects. Consider avoiding this product if you have a history of substance abuse.’ Botanic Tonics litigation. Without FDA-mandated dosing standards for kratom products, the actual alkaloid concentration in any individual Feel Free bottle cannot be reliably predicted by consumers. 

Is Feel Free FDA Approved?

No. Feel Free is not FDA approved. The FDA has not approved kratom for any medical use, and says it cannot be lawfully marketed in the US as a drug, a dietary supplement or a food additive. In 2018 the agency published modelling evidence that kratom’s compounds act on the same receptors as opioid drugs. In May 2023, the FDA seized approximately 250,000 bottles of Feel Free, citing inadequate safety data for kratom as a dietary ingredient. The case was later dropped, but neither kratom nor kava in Feel Free has undergone FDA safety review for use as a food or drug ingredient. 

Do You Have to Be 21 to Buy Feel Free Tonic?

Age requirements for Feel Free vary by state and retailer. As part of the Torres v. The settlement did not impose an age restriction. It required Botanic Tonics to add a warning to all kratom-containing Feel Free labels and to its social media advertising. Any minimum purchase age depends on state and local law and on individual retailers, not on this settlement. However, Feel Free has historically been sold without consistent age verification at gas stations and convenience stores. Several states with Kratom Consumer Protection Acts independently set their own minimum purchase ages. 

What Are Feel Free Withdrawal Symptoms?

Feel Free withdrawal symptoms include anxiety, restlessness, muscle aches, nausea, vomiting, diarrhea, insomnia, hot flashes, and intense cravings. Symptoms typically begin 8 to 24 hours after the last dose, as with other short-acting opioids, and the acute phase generally lasts 4 to 10 days (WHO clinical guidelines for withdrawal management). People who have used heavily for months describe low mood, poor sleep and craving persisting for weeks beyond the acute phase. 

References

1. Centers for Disease Control and Prevention. (2025). Increase in poison center reports linked to kratom-containing kava products, United States, 2000-2025. Morbidity and Mortality Weekly Report. https://www.cdc.gov/mmwr/volumes/75/wr/mm7512a1.htm
2. Food and Drug Administration. (2018). Statement on kratom. U.S. Department of Health and Human Services. https://www.fda.gov/news-events/press-announcements/statement-fda-and-scientific-evidence-kratom
3. National Institute on Drug Abuse. (2022). Kratom drug facts. https://nida.nih.gov/publications/drugfacts/kratom
4. Grundmann, O. (2021). Patterns of kratom use and health impact in the US. Drug and Alcohol Dependence, 222, 108-629.
5. Holstege, C. P., et al. (2025). Resurgence of kava-related poison center exposures and co-use with kratom. Morbidity and Mortality Weekly Report, 75(12).
6. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing.
7. Rettner, R. (2025, August 26). Why Feel Free, a drink with kratom and kava, has many saying they’re becoming addicted. CNN Health.
8. Shoichet, C. E. (2025, August 7). Users report serious health effects from kratom-containing herbal supplement. Fox News Health.